|
|
|
Insider
Information: |
Arbuckle Stuart A |
Relationship: |
Director |
City: |
Cambridge, |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
62,795 |
|
Indirect Shares
|
140 |
|
|
Direct
Value |
$22,712,016 |
|
|
Indirect Value
|
$63,973 |
|
|
Total
Shares |
62,935 |
|
|
Total
Value |
$22,775,989 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2024-05-15 |
49,691 |
2024-05-15 |
140 |
Premium* |
|
Dare Bioscience Inc |
DARE |
Director |
2017-01-03 |
13,104 |
2016-10-03 |
0 |
Premium* |
|
Immunogen Inc |
IMGN |
Director |
2024-02-12 |
0 |
2023-06-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
192 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-18 |
4 |
AS |
$242.08 |
$761,842 |
D/D |
(3,128) |
41,711 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-09 |
4 |
D |
$422.74 |
$1,343,045 |
D/D |
(3,177) |
80,013 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2023-02-10 |
4 |
D |
$294.33 |
$992,481 |
D/D |
(3,372) |
92,880 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-20 |
4 |
D |
$420.58 |
$1,418,616 |
D/D |
(3,373) |
67,846 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2024-02-21 |
4 |
AS |
$421.77 |
$1,519,637 |
D/D |
(3,603) |
59,439 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-25 |
4 |
AS |
$229.78 |
$849,418 |
D/D |
(3,634) |
35,179 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2021-02-25 |
4 |
AS |
$211.39 |
$775,989 |
D/D |
(3,634) |
41,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
OE |
$77.31 |
$282,182 |
D/D |
3,650 |
108,541 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
OE |
$86.52 |
$330,578 |
D/D |
3,708 |
50,460 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-06-29 |
4 |
AS |
$169.00 |
$626,652 |
D/D |
(3,708) |
46,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-11-04 |
4 |
AS |
$201.62 |
$747,607 |
D/D |
(3,708) |
33,240 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2019-11-04 |
4 |
OE |
$86.52 |
$330,578 |
D/D |
3,708 |
34,793 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-03 |
4 |
OE |
$86.52 |
$330,756 |
D/D |
3,710 |
36,950 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Commercial Officer |
|
2020-02-03 |
4 |
AS |
$228.90 |
$857,465 |
D/D |
(3,710) |
33,240 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-02-13 |
4 |
AS |
$88.39 |
$335,175 |
D/D |
(3,792) |
127,455 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2018-02-13 |
4 |
AS |
$151.40 |
$614,001 |
D/D |
(4,044) |
51,657 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2015-11-16 |
4 |
AS |
$121.95 |
$504,852 |
D/D |
(4,077) |
104,464 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, COO |
|
2022-02-17 |
4 |
D |
$232.51 |
$959,336 |
D/D |
(4,126) |
72,312 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
AS |
$112.07 |
$478,121 |
D/D |
(4,250) |
117,264 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2014-11-05 |
4 |
OE |
$45.11 |
$191,718 |
D/D |
4,250 |
121,514 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
AS |
$155.72 |
$661,810 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-03 |
4 |
OE |
$109.14 |
$463,845 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
OE |
$77.31 |
$328,568 |
D/D |
4,250 |
125,367 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-08-07 |
4 |
AS |
$152.88 |
$649,740 |
D/D |
(4,250) |
121,117 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVPChief Commercial Officer |
|
2017-11-06 |
4 |
AS |
$148.17 |
$629,723 |
D/D |
(4,250) |
41,952 |
0 |
- |
|
192 Records found
|
|
Page 4 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|